Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 34.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 703,104
  • Market Cap: £125.61m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,668,817
Richard John Rees 2,805,902 £975,051
Craig Jonathan Gulliford 1,630,466 £566,587
John Bradshaw 1,371,082 £476,451
David Gerard Woods 440,255 £152,989
Charles Spicer 308,530 £107,214
Ivonne Cantu 125,000 £43,438

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £13,657,815
Development Bank of Wales plc 14,376,727 £4,995,913
Finance Wales 12,776,727 £4,439,913
Baillie Gifford & Co 12,537,441 £4,356,761
Creo Medical Group EBT 10,000,000 £3,475,000
M&G Investments 9,428,500 £3,276,404
The Capital Group Companies, Inc. 8,816,807 £3,063,840
AXA Framlington Investment Managers 7,992,961 £2,777,554
Hargreave Hale Limited 6,753,632 £2,346,887
Tellworth Investments 5,772,778 £2,006,040
Hoya Corporation 4,799,880 £1,667,958
Jonathan Craton 3,400,294 £1,181,602
Cotterford Co Limited 3,335,398 £1,159,051
Mark Farmer 3,121,607 £1,084,758
RBC Trustees (CI) Ltd 2,974,727 £1,033,718
Angel Co Fund 2,967,120 £1,031,074

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 34.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.10
52 Week Low 23.25
Volume 703,104
Shares Issued 361.48m
Market Cap £125.61m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.79% below the market average20.79% below the market average20.79% below the market average20.79% below the market average20.79% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
15.55% below the market average15.55% below the market average15.55% below the market average15.55% below the market average15.55% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average
Income Not Available
Growth
43.43% above the market average43.43% above the market average43.43% above the market average43.43% above the market average43.43% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 08-May-2024

Time Volume / Share Price
17:07 85,262 @ 34.75p
15:30 1,934 @ 34.60p
15:03 50,000 @ 34.68p
13:55 573 @ 34.89p
13:45 7,498 @ 34.89p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page